Deep Track Capital as of June 30, 2026
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 66 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Guardant Health (GH) | 7.4 | $509M | 3.4M | 150.03 | |
| Immunovant (IMVT) | 5.2 | $360M | 9.3M | 38.53 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.7 | $254M | 4.7M | 53.67 | |
| Vaxcyte (PCVX) | 3.6 | $250M | 4.3M | 58.13 | |
| Alnylam Pharmaceuticals (ALNY) | 3.6 | $248M | 825k | 301.03 | |
| Veradermics Common Stock (MANE) | 3.6 | $246M | 2.0M | 122.94 | |
| Genmab A/s Sponsored Ads (GMAB) | 3.5 | $238M | 8.7M | 27.47 | |
| Tarsus Pharmaceuticals (TARS) | 3.4 | $231M | 3.7M | 62.94 | |
| Nuvalent Inc-a (NUVL) | 3.2 | $220M | 1.8M | 123.50 | |
| Alkermes SHS (ALKS) | 3.1 | $210M | 4.0M | 52.40 | |
| Ocular Therapeutix (OCUL) | 2.8 | $193M | 20M | 9.82 | |
| BioMarin Pharmaceutical (BMRN) | 2.8 | $189M | 3.3M | 57.22 | |
| Nurix Therapeutics (NRIX) | 2.7 | $188M | 7.7M | 24.26 | |
| Oruka Therapeutics (ORKA) | 2.7 | $183M | 1.9M | 95.17 | |
| Alumis (ALMS) | 2.6 | $179M | 6.3M | 28.14 | |
| Ionis Pharmaceuticals (IONS) | 2.5 | $174M | 2.2M | 79.29 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.5 | $172M | 12M | 14.15 | |
| Vera Therapeutics Cl A (VERA) | 2.5 | $172M | 4.0M | 42.91 | |
| Axsome Therapeutics (AXSM) | 2.5 | $171M | 700k | 244.77 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 2.0 | $136M | 7.0M | 19.47 | |
| Hemab Therapeutics Hldgs Com Shs | 1.9 | $132M | 3.6M | 36.73 | |
| Tango Therapeutics (TNGX) | 1.9 | $131M | 4.2M | 31.26 | |
| Definium Therapeutics Com Shs (DFTX) | 1.9 | $129M | 2.8M | 47.04 | |
| Grail (GRAL) | 1.8 | $125M | 1.8M | 68.27 | |
| Bicara Therapeutics (BCAX) | 1.8 | $122M | 4.1M | 29.69 | |
| Maze Therapeatics (MAZE) | 1.6 | $111M | 3.7M | 29.84 | |
| Celldex Therapeutics Com New (CLDX) | 1.6 | $109M | 2.9M | 37.21 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 1.6 | $109M | 3.4M | 32.45 | |
| Mbx Biosciences (MBX) | 1.4 | $96M | 1.7M | 55.20 | |
| Gh Research Ordinary Shares (GHRS) | 1.3 | $90M | 3.3M | 26.88 | |
| Cogent Biosciences (COGT) | 1.1 | $77M | 2.0M | 38.70 | |
| Ataibeckley Com Shs (ATAI) | 1.1 | $76M | 14M | 5.27 | |
| United Therapeutics Corporation (UTHR) | 1.0 | $67M | 124k | 541.83 | |
| Avalo Therapeutics Com New (AVTX) | 1.0 | $67M | 3.6M | 18.48 | |
| Miragen Therapeutics (VRDN) | 1.0 | $66M | 3.6M | 18.37 | |
| Cytokinetics Com New (CYTK) | 0.9 | $60M | 700k | 85.19 | |
| Altimmune Com New (ALT) | 0.9 | $59M | 19M | 3.04 | |
| Personalis Ord (PSNL) | 0.8 | $54M | 4.0M | 13.40 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $49M | 9.3M | 5.29 | |
| Cormedix Inc cormedix (CRMD) | 0.7 | $49M | 6.3M | 7.85 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.7 | $48M | 700k | 68.65 | |
| Harrow Health (HROW) | 0.6 | $41M | 969k | 42.47 | |
| Corvus Pharmaceuticals (CRVS) | 0.5 | $37M | 2.5M | 14.94 | |
| Solid Biosciences Com New (SLDB) | 0.5 | $36M | 3.6M | 9.99 | |
| Beam Therapeutics (BEAM) | 0.5 | $34M | 1.0M | 34.32 | |
| Dyne Therapeutics (DYN) | 0.5 | $33M | 1.5M | 22.21 | |
| Immix Biopharma (IMMX) | 0.4 | $29M | 2.8M | 10.31 | |
| X4 Pharmaceuticals Com New (XFOR) | 0.4 | $28M | 5.9M | 4.67 | |
| Shattuck Labs (STTK) | 0.4 | $26M | 3.7M | 6.94 | |
| Mannkind Corp Com New (MNKD) | 0.4 | $26M | 6.0M | 4.26 | |
| Century Therapeutics (IPSC) | 0.3 | $23M | 9.5M | 2.45 | |
| Generate Biomedicines Com Shs (GENB) | 0.3 | $23M | 1.3M | 16.87 | |
| Verastem Com New (VSTM) | 0.3 | $22M | 5.7M | 3.82 | |
| Kura Oncology (KURA) | 0.3 | $22M | 2.0M | 10.97 | |
| Enanta Pharmaceuticals (ENTA) | 0.3 | $21M | 1.4M | 14.58 | |
| Nektar Therapeutics Com New (NKTR) | 0.3 | $21M | 300k | 69.81 | |
| Olema Pharmaceuticals (OLMA) | 0.3 | $19M | 1.5M | 12.51 | |
| Kailera Therapeutics Common Stock | 0.2 | $15M | 700k | 22.03 | |
| Kardigan Ord | 0.2 | $14M | 600k | 23.85 | |
| Enliven Therapeutics (ELVN) | 0.2 | $11M | 225k | 50.75 | |
| Promis Neurosciences Com Shs (PMN) | 0.2 | $11M | 836k | 13.16 | |
| Immunocore Hldgs Ads (IMCR) | 0.1 | $9.9M | 311k | 31.75 | |
| Xencor (XNCR) | 0.1 | $9.6M | 594k | 16.10 | |
| Context Therapeutics (CNTX) | 0.1 | $4.1M | 7.4M | 0.55 | |
| Inventiva Sa Ads (IVA) | 0.0 | $3.0M | 800k | 3.78 | |
| Aligos Therapeutics Com New (ALGS) | 0.0 | $2.6M | 444k | 5.77 |